Lost Money on Voyager Therapeutics, Inc.(VYGR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Voyager Therapeutics, Inc. (NASDAQ: VYGR) for potential federal securities law violations. This follows Voyager's announcement of issues with its gene therapy program for ALS, specifically with the siRNA payload component of VY9323.
February 13, 2025 | 10:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations. The company announced issues with its ALS gene therapy program, which may impact investor confidence.
The investigation by Levi & Korsinsky into potential securities law violations, combined with the announcement of issues in Voyager's ALS gene therapy program, is likely to negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100